Microbiology and Infectious Diseases Research Funding

The UKCRC Partners have been working together to improve research into microbiology and infectious diseases in the UK.

In 2006, several funders joined forces under the UKCRC umbrella to form a Strategic Planning Group (SPG) to carry out actions to strengthen the research base in this area. The findings of the SPG are detailed in the report Developing Microbiology and Infectious Diseases Research in the UK.

The main outcome of the SPG was a commitment from a consortium of seven funders to fund the UKCRC Translational Infection Research Initiative (TIRI).

The initiative is designed to foster multi-disciplinary collaboration, boost research infrastructure, and promote training and career development, through two routes:

  • Consortium Grants – to support new research partnerships. The consortia will focus on high quality, collaborative research targeted at national priority areas. They will establish new career development and training programmes and carry out multi-disciplinary research
  • Strategy Development Grants – to develop new partnerships and improved research bids. The bids will be based on meaningful strategies and address evidence gaps.

The four UKCRC TIRI Consortia are:

The seven organisations involved in the UKCRC Translational Infection Research Initiative are:

  • Biotechnology and Biological Sciences Research Council
  • Medical Research Council
  • National Institute for Health Research
  • Health and Social Care Research and Development Office, Northern Ireland
  • Chief Scientist Office, Scottish Government Health Directorates
  • National Institute for Social Care and Health Research (Welsh Assembly Government)
  • Wellcome Trust

In 2017 a review led by the MRC found that the objectives of TIRI had been met by these consortia. They have successfully built capacity in multidisciplinary areas of translational infection research. They have brought together a wide range of researchers to create a multidisciplinary programme and have maintained strong collaborative links with these researchers. This initiative has resulted in outputs that will build on the legacy left by these awards for translational infection.